Physician profile
David Haas
NPI 1518924471
$2,337.78
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $334 · 2021: $412 · 2022: $528 · 2023: $307 · 2024: $17.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $484.30 | 2019-2023 | Spravato |
| Otsuka America Pharmaceutical, INC. | $423.05 | 2019-2023 | Rexulti |
| Allergan, INC. | $349.45 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $205.67 | 2019-2022 | |
| Abbvie INC. | $143.40 | 2021-2023 | |
| Lundbeck LLC | $102.62 | 2019-2022 | |
| Alkermes, INC. | $94.50 | 2022-2023 | Aristada, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $91.27 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $71.72 | 2021-2024 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $50.44 | 2019 | |
| Shire North American Group INC | $47.69 | 2019 | |
| Vanda Pharmaceuticals INC. | $45.10 | 2020-2021 | |
| Neuronetics, INC. | $36.09 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $30.76 | 2021 | |
| Bausch Health US, LLC | $29.28 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $27.09 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.12 | 2020 | |
| Corium, LLC | $21.81 | 2023 | Azstarys |
| Tris Pharma INC | $20.04 | 2022 | |
| Adlon Therapeutics L.P. | $19.40 | 2020 | |
| Idorsia Pharmaceuticals US INC | $17.98 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.